Article Publish Status: FREE
Abstract Title:

Humanβ-cell regeneration: progress, hurdles, and controversy.

Abstract Source:

Curr Opin Endocrinol Diabetes Obes. 2014 Apr ;21(2):102-8. PMID: 24569551

Abstract Author(s):

Agata Jurczyk, Rita Bortell, Laura C Alonso

Article Affiliation:

Agata Jurczyk

Abstract:

PURPOSE OF REVIEW: Therapies that increase functionalβ-cell mass may be the best long-term treatment for diabetes. Significant resources are devoted toward this goal, and progress is occurring at a rapid pace. Here, we summarize recent advances relevant to human β-cell regeneration.

RECENT FINDINGS: Newβ-cells arise from proliferation of pre-existing β-cells or transdifferentiation from other cell types. In addition, dedifferentiated β-cells may populate islets in diabetes, possibly representing a pool of cells that could redifferentiate into functional β-cells. Advances in finding strategiesto drive β-cell proliferation include new insight into proproliferative factors, both circulating and local, and elements intrinsic to the β-cell, such as cell cycle machinery and regulation of gene expression through epigenetic modification and noncoding RNAs. Controversy continues in the arena of generation of β-cells by transdifferentiation from exocrine, ductal, and alpha cells, with studies producing both supporting and opposing data. Progress has been made in redifferentiation of β-cells that have lost expression of β-cell markers.

SUMMARY: Although significant progress has been made, and promising avenues exist, more work is needed to achieve the goal ofβ-cell regeneration as a treatment for diabetes.

Study Type : Review

Print Options


This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.